Companies Attending

  • Adaptive Sensory Technology
  • Adverum Biotechnologies
  • Aerie Pharmaceuticals
  • Aerpio Therapeutics
  • Albert Einstein College of Medicine and Montefiore
  • Alcon
  • Alimera Sciences
  • Allegro Ophthalmics
  • Allergan
  • Apellis Pharmaceuticals
  • Aptitude Medical Systems
  • Aquilo Partners
  • AsclepiX Therapeutics
  • Associated Retina Specialist
  • ASRS
  • Astellas Pharma
  • Auckland Eye Limited
  • Bausch + Lomb
  • Baylor College of Medicine
  • Beaver Visitec International
  • Beth Israel Deaconess Medical Center
  • BioComm Network
  • BioTime
  • Boehringer Ingelheim Pharma
  • Bryn Mawr Communications
  • Burns McClellan
  • Byers Eye Institute at Stanford
  • California Retina Consultants
  • Cambridge Consultants
  • Carl Zeiss Meditec
  • Cell Care Therapeutics
  • Center for Retinal and Macular Diseases
  • Charles Retina Institute
  • Clarus Funds
  • Clearside Biomedical
  • Cydan
  • DigiSight Technologies
  • Drusolv Therapeutics
  • Duke Eye Center
  • Esteve
  • Ethis Communications
  • Evolve Medical Education
  • Evolve Therapeutics
  • ExSight Ventures
  • Eyedaptic
  • Foresite Capital
  • ForSight Labs
  • Fortress Biotech
  • Gemini Therapeutics
  • Genentech
  • Gensight Biologics
  • Glaucoma Technologies
  • Graybug Vision
  • Hatteras Venture Partners
  • Haug Partners
  • Heidelberg Engineering
  • Hemera Biosciences
  • Homology Medicines
  • Illinois Retina Associates
  • Indiana University School of Medicine
  • InterWest Partners
  • isonic Medical
  • Istanbul Bilim University
  • JPA Health Communications
  • Kodiak Sciences
  • Lagunita Biosciences
  • Laidlaw
  • Lexitas Pharma Services
  • Lifecore Biomedical
  • Long Island Vitreo Retinal
  • LSU Health-Shreveport
  • Merck
  • Mimetogen Pharmaceuticals
  • Miracles In Sight
  • Mitotech
  • Multi Radiance Medical
  • NEA
  • NeuMedics
  • Nightstar
  • Notal Vision
  • Novartis
  • Ocular Therapeutix
  • OCULUS Surgical
  • Ocunexus Therapeutics
  • Ohr Pharmaceutical
  • Omar Consulting Group
  • ONL Therapeutics
  • Ophthalmic Consultants of Boston
  • Ophthotech
  • Opthea Limited
  • Optimal Acuity
  • Ora
  • Oxular
  • Oyster Point Pharmaceuticals
  • Pamdeca
  • Patterson Thuente IP
  • PentaVision
  • PharmaQuest Associates
  • Piper Jaffray
  • ProFarma
  • Promedica International
  • pSivida
  • RA Capital Management
  • Regeneron
  • REGENXBIO
  • Retina Specialist
  • Retinal Consultants of Arizona
  • Retina-Vitreous Associated Medical Group
  • Santen
  • Santen Pharmaceuticals Ltd.
  • SciFluor Life Sciences
  • Scotia Vision
  • SeeCare Technologies
  • Shire
  • Stealth BioTherapeutics
  • Stein Eye Institute, UCLA
  • Stephens
  • Tennessee Retina
  • The Fundingsland Group
  • The Magnum Group
  • The Ohio State University
  • The Ritedose Corporation
  • ThromboGenics NV
  • TPG Capital
  • Translatum Medicus inc
  • Trial Runners
  • TrueVision Systems
  • Tufts Medical Center
  • UCL and Imperial College London, Western Eye Hospital London
  • University of Michigan
  • University of Southern California
  • University of Southern California & Los Angeles County – USC Medical Center
  • USC Roski Eye Institute, Keck Medicine of USC
  • Valley Retina Research
  • Vestrum Health
  • Vision Ophthalmic Development International
  • VisionCare
  • Vitreous Retina Macula Consultants of New York
  • Weill Cornell Medical College
  • West Coast Retina
  • Yale University School of Medicine